{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T04:56:21Z","timestamp":1763441781015,"version":"3.45.0"},"reference-count":145,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T00:00:00Z","timestamp":1751932800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T00:00:00Z","timestamp":1751932800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s10620-025-09199-1","type":"journal-article","created":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T05:57:47Z","timestamp":1751954267000},"page":"3621-3633","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Health Maintenance and Unique Health Needs of the Perimenopausal and Postmenopausal Woman with Inflammatory Bowel Disease"],"prefix":"10.1007","volume":"70","author":[{"given":"Grace","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Ching","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youstina","family":"Hanna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parul","family":"Tandon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivian","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,8]]},"reference":[{"key":"9199_CR1","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1097\/gme.0b013e31824d8f40.","volume":"19","author":"SD Harlow","year":"2012","unstructured":"Harlow SD, Gass M, Hall JE et al. Executive summary of the stages of reproductive aging workshop +10: addressing the unfinished agenda of staging reproductive aging. Menopause. 2012;19:387\u2013395. https:\/\/doi.org\/10.1097\/gme.0b013e31824d8f40.","journal-title":"Menopause."},{"key":"9199_CR2","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1097\/0000000000000736.","volume":"24","author":"P Paramsothy","year":"2017","unstructured":"Paramsothy P, Harlow SD, Nan B et al. Duration of the menopausal transition is longer in women with young age at onset: the multi-ethnic Study of Women\u2019s Health across the Nation. Menopause. 2017;24:142\u2013149. https:\/\/doi.org\/10.1097\/0000000000000736.","journal-title":"Menopause."},{"key":"9199_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11894-019-0669-6.","volume":"21","author":"B Click","year":"2019","unstructured":"Click B, Regueiro M. Managing risks with biologics. Curr Gastroenterol Rep. 2019;21:1. https:\/\/doi.org\/10.1007\/s11894-019-0669-6.","journal-title":"Curr Gastroenterol Rep."},{"key":"9199_CR4","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/ajg.2016.537.","volume":"112","author":"FA Farraye","year":"2017","unstructured":"Farraye FA, Melmed GY, Lichtenstein GR, Kane SV. ACG clinical guideline: preventive care in inflammatory bowel disease. Am J Gastroenterol. 2017;112:241\u2013258. https:\/\/doi.org\/10.1038\/ajg.2016.537.","journal-title":"Am J Gastroenterol."},{"key":"9199_CR5","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1093\/ibd\/izx062.","volume":"24","author":"HMJL Hazenberg","year":"2018","unstructured":"Hazenberg HMJL, de Boer NKH, Mulder CJJ, Mom SH, van Bodegraven AA, Tack GJ. Neoplasia and precursor lesions of the female genital tract in IBD: epidemiology, role of immunosuppressants, and clinical implications. Inflamm Bowel Dis. 2018;24:510\u2013531. https:\/\/doi.org\/10.1093\/ibd\/izx062.","journal-title":"Inflamm Bowel Dis."},{"key":"9199_CR6","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1093\/ibd\/izz185.","volume":"26","author":"J Roseira","year":"2020","unstructured":"Roseira J, Magro F, Fernandes S et al. Sexual quality of life in inflammatory bowel disease: a multicenter National-Level Study. Inflamm Bowel Dis. 2020;26:746\u2013755. https:\/\/doi.org\/10.1093\/ibd\/izz185.","journal-title":"Inflamm Bowel Dis."},{"key":"9199_CR7","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1093\/ecco-jcc\/jjv140.","volume":"9","author":"G Mantzouranis","year":"2015","unstructured":"Mantzouranis G, Fafliora E, Glanztounis G, Christodoulou D, Katsanos KH. Inflammatory bowel disease and sexual function in male and female patients: an update on evidence in the past 10 years. J Crohns Colitis. 2015;9:1160\u20131168. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjv140.","journal-title":"J Crohns Colitis."},{"key":"9199_CR8","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1002\/ibd.21090.","volume":"16","author":"KR Muller","year":"2010","unstructured":"Muller KR, Prosser R, Bampton P, Mountifield R, Andrews JM. Female gender and surgery impair relationships, body image, and sexuality in inflammatory bowel disease: patient perceptions. Inflamm Bowel Dis. 2010;16:657\u2013663. https:\/\/doi.org\/10.1002\/ibd.21090.","journal-title":"Inflamm Bowel Dis."},{"key":"9199_CR9","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/j.dld.2023.01.149.","volume":"55","author":"S Vieujean","year":"2023","unstructured":"Vieujean S, De Vos M, D\u2019Amico F et al. Inflammatory bowel disease meets fertility: a physician and patient survey. Dig Liver Dis. 2023;55:888\u2013898. https:\/\/doi.org\/10.1016\/j.dld.2023.01.149.","journal-title":"Dig Liver Dis."},{"key":"9199_CR10","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1093\/ibd\/izac204.","volume":"29","author":"TC Mules","year":"2023","unstructured":"Mules TC, Swaminathan A, Hirschfeld E et al. The impact of disease activity on sexual and erectile dysfunction in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2023;29:1244\u20131254. https:\/\/doi.org\/10.1093\/ibd\/izac204.","journal-title":"Inflamm Bowel Dis."},{"key":"9199_CR11","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1111\/codi.15375.","volume":"23","author":"R Boudiaf","year":"2021","unstructured":"Boudiaf R, Bouchard D, Rivi\u00e8re P et al. Assessment of sexual dysfunction in patients with perianal Crohn\u2019s disease. Colorectal Dis. 2021;23:114\u2013122. https:\/\/doi.org\/10.1111\/codi.15375.","journal-title":"Colorectal Dis."},{"key":"9199_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/00926230590475206.","volume":"31","author":"M Wiegel","year":"2005","unstructured":"Wiegel M, Meston C, Rosen R. The female sexual function index (FSFI): cross-validation and development of clinical cutoff scores. J Sex Marital Ther. 2005;31:1\u201320. https:\/\/doi.org\/10.1080\/00926230590475206.","journal-title":"J Sex Marital Ther."},{"key":"9199_CR13","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1080\/009262300278597.","volume":"26","author":"R Rosen","year":"2000","unstructured":"Rosen R, Brown C, Heiman J et al. The female sexual function index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther. 2000;26:191\u2013208. https:\/\/doi.org\/10.1080\/009262300278597.","journal-title":"J Sex Marital Ther."},{"key":"9199_CR14","doi-asserted-by":"publisher","first-page":"118","DOI":"10.4067\/S0717-75262004000200006.","volume":"69","author":"JE Bl\u00fcmel","year":"2004","unstructured":"Bl\u00fcmel JE, Binfa EL, Cataldo AP, Carrasco VA, Izaguirre LH, Sarr\u00e1 CS. \u00cdndice de Funci\u00f3n Sexual Femenina: Un test para evaluar la sexualidad de la mujer. Rev Chil Obstet Ginecol. 2004;69:118\u2013125. https:\/\/doi.org\/10.4067\/S0717-75262004000200006.","journal-title":"Rev Chil Obstet Ginecol."},{"key":"9199_CR15","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jsxm.2019.10.007.","volume":"17","author":"CM Meston","year":"2020","unstructured":"Meston CM, Freihart BK, Handy AB, Kilimnik CD, Rosen RC. Scoring and Interpretation of the FSFI: what can be learned from 20 years of use? J Sex Med. 2020;17:17\u201325. https:\/\/doi.org\/10.1016\/j.jsxm.2019.10.007.","journal-title":"J Sex Med."},{"key":"9199_CR16","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1093\/ibd\/izy397.","volume":"25","author":"E Shmidt","year":"2019","unstructured":"Shmidt E, Su\u00e1rez-Fari\u00f1as M, Mallette M et al. A longitudinal study of sexual function in women with newly diagnosed inflammatory bowel disease. Inflamm Bowel Dis. 2019;25:1262\u20131270. https:\/\/doi.org\/10.1093\/ibd\/izy397.","journal-title":"Inflamm Bowel Dis."},{"key":"9199_CR17","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1111\/j.1743-6109.2007.00496.x.","volume":"4","author":"M Sand","year":"2007","unstructured":"Sand M, Fisher WA. Women\u2019s endorsement of models of female sexual response: The nurses\u2019 sexuality study. J Sex Med. 2007;4:708\u2013719. https:\/\/doi.org\/10.1111\/j.1743-6109.2007.00496.x.","journal-title":"J Sex Med."},{"key":"9199_CR18","doi-asserted-by":"publisher","first-page":"e32279","DOI":"10.1097\/MD.0000000000032279.","volume":"101","author":"F Pires","year":"2022","unstructured":"Pires F, Martins D, Ministro P. A survey on the impact of IBD in sexual health: into intimacy. Medicine (Baltimore). 2022;101:e32279. https:\/\/doi.org\/10.1097\/MD.0000000000032279.","journal-title":"Medicine (Baltimore)."},{"key":"9199_CR19","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1093\/jcag\/gwae048.","volume":"8","author":"AV Weizman","year":"2024","unstructured":"Weizman AV, Nguyen DM, Targownik LE et al. Associations with sexual dysfunction among a Canadian cohort with inflammatory bowel disease. J Can Assoc Gastroenterol. 2024;8:31\u201338. https:\/\/doi.org\/10.1093\/jcag\/gwae048.","journal-title":"J Can Assoc Gastroenterol."},{"key":"9199_CR20","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1471-230X-8-45.","volume":"8","author":"A Timmer","year":"2008","unstructured":"Timmer A, Kemptner D, Bauer A, Takses A, Ott C, F\u00fcrst A. Determinants of female sexual function in inflammatory bowel disease: a survey based cross-sectional analysis. BMC Gastroenterol. 2008;8:45. https:\/\/doi.org\/10.1186\/1471-230X-8-45.","journal-title":"BMC Gastroenterol."},{"key":"9199_CR21","doi-asserted-by":"publisher","first-page":"e344","DOI":"10.1016\/j.crohns.2013.04.008.","volume":"7","author":"SR Knowles","year":"2013","unstructured":"Knowles SR, Gass C, Macrae F. Illness perceptions in IBD influence psychological status, sexual health and satisfaction, body image and relational functioning: a preliminary exploration using structural equation modeling. J Crohns Colitis. 2013;7:e344\u2013e350. https:\/\/doi.org\/10.1016\/j.crohns.2013.04.008.","journal-title":"J Crohns Colitis."},{"key":"9199_CR22","doi-asserted-by":"publisher","first-page":"881485","DOI":"10.3389\/fendo.2022.881485.","volume":"13","author":"J Zhang","year":"2022","unstructured":"Zhang J, Nie J, Zou M et al. Prevalence and associated factors of sexual dysfunction in patients with inflammatory bowel disease. Front Endocrinol (Lausanne). 2022;13:881485. https:\/\/doi.org\/10.3389\/fendo.2022.881485.","journal-title":"Front Endocrinol (Lausanne)."},{"key":"9199_CR23","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1001\/archpsyc.63.4.385.","volume":"63","author":"LS Cohen","year":"2006","unstructured":"Cohen LS, Soares CN, Vitonis AF, Otto MW, Harlow BL. Risk for new onset of depression during the menopausal transition: the harvard study of moods and cycles. Arch Gen Psychiatry. 2006;63:385\u2013390. https:\/\/doi.org\/10.1001\/archpsyc.63.4.385.","journal-title":"Arch Gen Psychiatry."},{"key":"9199_CR24","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1097\/GME.0b013e3182730599.","volume":"20","author":"JT Bromberger","year":"2013","unstructured":"Bromberger JT, Kravitz HM, Chang Y et al. Does risk for anxiety increase during the menopausal transition? study of women\u2019s health across the nation. Menopause. 2013;20:488\u2013495. https:\/\/doi.org\/10.1097\/GME.0b013e3182730599.","journal-title":"Menopause."},{"key":"9199_CR25","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.cgh.2019.05.018.","volume":"18","author":"S Ona","year":"2020","unstructured":"Ona S, James K, Ananthakrishnan AN et al. Association between Vulvovaginal discomfort and activity of inflammatory bowel diseases. Clin Gastroenterol Hepatol. 2020;18:604-611.e1. https:\/\/doi.org\/10.1016\/j.cgh.2019.05.018.","journal-title":"Clin Gastroenterol Hepatol."},{"key":"9199_CR26","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.ecl.2015.05.009.","volume":"44","author":"K Thornton","year":"2015","unstructured":"Thornton K, Chervenak J, Neal-Perry G. Menopause and sexuality. Endocrinol Metab Clin North Am. 2015;44:649\u2013661. https:\/\/doi.org\/10.1016\/j.ecl.2015.05.009.","journal-title":"Endocrinol Metab Clin North Am."},{"key":"9199_CR27","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1097\/SLA.0b013e318250caa9.","volume":"256","author":"SAL Bartels","year":"2012","unstructured":"Bartels SAL, D\u2019Hoore A, Cuesta MA, Bensdorp AJ, Lucas C, Bemelman WA. Significantly increased pregnancy rates after laparoscopic restorative proctocolectomy: a cross-sectional study. Ann Surg. 2012;256:1045\u20131048. https:\/\/doi.org\/10.1097\/SLA.0b013e318250caa9.","journal-title":"Ann Surg."},{"key":"9199_CR28","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1007\/s00535-012-0700-2.","volume":"48","author":"L Mar\u00edn","year":"2013","unstructured":"Mar\u00edn L, Ma\u00f1osa M, Garcia-Planella E et al. Sexual function and patients\u2019 perceptions in inflammatory bowel disease: a case-control survey. J Gastroenterol. 2013;48:713\u2013720. https:\/\/doi.org\/10.1007\/s00535-012-0700-2.","journal-title":"J Gastroenterol."},{"key":"9199_CR29","first-page":"150","volume":"17","author":"O Kanar","year":"2017","unstructured":"Kanar O, Berry AC, Nakshabendi R et al. Effects of immunomodulators and biologic agents on sexual health in patients with inflammatory bowel disease. Ochsner J. 2017;17:150\u2013156.","journal-title":"Ochsner J."},{"key":"9199_CR30","doi-asserted-by":"publisher","first-page":"166","DOI":"10.34172\/mejdd.2024.384.","volume":"16","author":"M Soheilipour","year":"2024","unstructured":"Soheilipour M, Tamizi Far B, Fadaei R, Adibi P. Comparison of pelvic floor dysfunction in women with Ulcerative Colitis and healthy population. Middle East J Dig Dis. 2024;16:166\u2013172. https:\/\/doi.org\/10.34172\/mejdd.2024.384.","journal-title":"Middle East J Dig Dis."},{"key":"9199_CR31","first-page":"249","volume":"61","author":"A Bondurri","year":"2015","unstructured":"Bondurri A, Maffioli A, Danelli P. Pelvic floor dysfunction in inflammatory bowel disease. Minerva Gastroenterol Dietol. 2015;61:249\u2013259.","journal-title":"Minerva Gastroenterol Dietol."},{"key":"9199_CR32","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1093\/ibd\/izy344.","volume":"25","author":"AJ Khera","year":"2019","unstructured":"Khera AJ, Chase JW, Salzberg M, Thompson AJV, Kamm MA. Gut-directed pelvic floor behavioral treatment for fecal incontinence and constipation in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2019;25:620\u2013626. https:\/\/doi.org\/10.1093\/ibd\/izy344.","journal-title":"Inflamm Bowel Dis."},{"key":"9199_CR33","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1080\/00365521.2022.2039280.","volume":"57","author":"AJ Khera","year":"2022","unstructured":"Khera AJ, Chase JW, Stillman BC et al. Pelvic floor behavioral treatment for fecal incontinence and constipation in quiescent inflammatory bowel disease. Scand J Gastroenterol. 2022;57:807\u2013813. https:\/\/doi.org\/10.1080\/00365521.2022.2039280.","journal-title":"Scand J Gastroenterol."},{"key":"9199_CR34","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/ibd.20955.","volume":"16","author":"ML Borum","year":"2010","unstructured":"Borum ML, Igiehon E, Shafa S. Physicians may inadequately address sexuality in women with inflammatory bowel disease. Inflamm Bowel Dis. 2010;16:181. https:\/\/doi.org\/10.1002\/ibd.20955.","journal-title":"Inflamm Bowel Dis."},{"key":"9199_CR35","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1111\/codi.15598.","volume":"23","author":"NB Dames","year":"2021","unstructured":"Dames NB, Squire SE, Devlin AB et al. \u2018Let\u2019s talk about sex\u2019: a patient-led survey on sexual function after colorectal and pelvic floor surgery. Colorectal Dis. 2021;23:1524\u20131551. https:\/\/doi.org\/10.1111\/codi.15598.","journal-title":"Colorectal Dis."},{"key":"9199_CR36","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1093\/ibd\/izy202.","volume":"24","author":"PS de Silva","year":"2018","unstructured":"de Silva PS, O\u2019Toole A, Marc LG et al. Development of a sexual dysfunction scale for women with inflammatory bowel disease. Inflamm Bowel Dis. 2018;24:2350\u20132359. https:\/\/doi.org\/10.1093\/ibd\/izy202.","journal-title":"Inflamm Bowel Dis."},{"key":"9199_CR37","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1002\/ibd.20082.","volume":"13","author":"SR Marri","year":"2007","unstructured":"Marri SR, Ahn C, Buchman AL. Voluntary childlessness is increased in women with inflammatory bowel disease. Inflamm Bowel Dis. 2007;13:591\u2013599. https:\/\/doi.org\/10.1002\/ibd.20082.","journal-title":"Inflamm Bowel Dis."},{"key":"9199_CR38","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1093\/ecco-jcc\/jjw078.","volume":"10","author":"CP Selinger","year":"2016","unstructured":"Selinger CP, Ghorayeb J, Madill A. What factors might drive Voluntary Childlessness (VC) in women with IBD? does IBD-specific pregnancy-related knowledge matter? J Crohns Colitis. 2016;10:1151\u20131158. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjw078.","journal-title":"J Crohns Colitis."},{"key":"9199_CR39","doi-asserted-by":"publisher","first-page":"e206","DOI":"10.1016\/j.crohns.2012.09.010.","volume":"7","author":"CP Selinger","year":"2013","unstructured":"Selinger CP, Eaden J, Selby W et al. Inflammatory bowel disease and pregnancy: lack of knowledge is associated with negative views. J Crohns Colitis. 2013;7:e206-213. https:\/\/doi.org\/10.1016\/j.crohns.2012.09.010.","journal-title":"J Crohns Colitis."},{"key":"9199_CR40","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1155\/2015\/715354.","volume":"29","author":"VW Huang","year":"2015","unstructured":"Huang VW, Chang HJ, Kroeker KI et al. Does the level of reproductive knowledge specific to inflammatory bowel disease predict childlessness among women with inflammatory bowel disease? Can J Gastroenterol Hepatol. 2015;29:95\u2013103. https:\/\/doi.org\/10.1155\/2015\/715354.","journal-title":"Can J Gastroenterol Hepatol."},{"key":"9199_CR41","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1097\/MEG.0000000000001037.","volume":"30","author":"J Walldorf","year":"2018","unstructured":"Walldorf J, Brunne S, Gittinger FS, Michl P. Family planning in inflammatory bowel disease: childlessness and disease-related concerns among female patients. Eur J Gastroenterol Hepatol. 2018;30:310\u2013315. https:\/\/doi.org\/10.1097\/MEG.0000000000001037.","journal-title":"Eur J Gastroenterol Hepatol."},{"key":"9199_CR42","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1093\/humupd\/dmr026.","volume":"17","author":"M Mills","year":"2011","unstructured":"Mills M, Rindfuss RR, McDonald P, Te Velde E, ESHRE Reproduction and Society Task Force. Why do people postpone parenthood? reasons and social policy incentives. Human Reprod Update. 2011;17:848\u2013860. https:\/\/doi.org\/10.1093\/humupd\/dmr026.","journal-title":"Human Reprod Update."},{"key":"9199_CR43","doi-asserted-by":"publisher","first-page":"e56583","DOI":"10.1371\/journal.pone.0056583.","volume":"8","author":"LC Kenny","year":"2013","unstructured":"Kenny LC, Lavender T, McNamee R, O\u2019Neill SM, Mills T, Khashan AS. Advanced maternal age and adverse pregnancy outcome: evidence from a large contemporary cohort. PLoS ONE. 2013;8:e56583. https:\/\/doi.org\/10.1371\/journal.pone.0056583.","journal-title":"PLoS ONE."},{"key":"9199_CR44","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/1471-0528.12659.","volume":"121","author":"M Laopaiboon","year":"2014","unstructured":"Laopaiboon M, Lumbiganon P, Intarut N et al. Advanced maternal age and pregnancy outcomes: a multicountry assessment. BJOG. 2014;121:49\u201356. https:\/\/doi.org\/10.1111\/1471-0528.12659.","journal-title":"BJOG."},{"key":"9199_CR45","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1136\/gut.2005.090316.","volume":"55","author":"A Waljee","year":"2006","unstructured":"Waljee A, Waljee J, Morris AM, Higgins PDR. Threefold increased risk of infertility: a meta-analysis of infertility after ileal pouch anal anastomosis in ulcerative colitis. Gut. 2006;55:1575\u20131580. https:\/\/doi.org\/10.1136\/gut.2005.090316.","journal-title":"Gut."},{"key":"9199_CR46","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/BF00699417.","volume":"9","author":"T \u00d6resland","year":"1994","unstructured":"\u00d6resland T, Palmblad S, Ellstr\u00f6m M, Berndtsson I, Crona N, Hult\u00e9n L. Gynaecological and sexual function related to anatomical changes in the female pelvis after restorative proctocolectomy. Int J Colorectal Dis. 1994;9:77\u201381. https:\/\/doi.org\/10.1007\/BF00699417.","journal-title":"Int J Colorectal Dis."},{"key":"9199_CR47","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/BF00300204.","volume":"6","author":"M Aszt\u00e9ly","year":"1991","unstructured":"Aszt\u00e9ly M, Palmblad S, Wikland M, Hult\u00e9n L. Radiological study of changes in the pelvis in women following proctocolectomy. Int J Colorectal Dis. 1991;6:103\u2013107. https:\/\/doi.org\/10.1007\/BF00300204.","journal-title":"Int J Colorectal Dis."},{"key":"9199_CR48","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.surg.2004.06.018.","volume":"136","author":"E Gorgun","year":"2004","unstructured":"Gorgun E, Remzi FH, Goldberg JM et al. Fertility is reduced after restorative proctocolectomy with ileal pouch anal anastomosis: a study of 300 patients. Surgery. 2004;136:795\u2013803. https:\/\/doi.org\/10.1016\/j.surg.2004.06.018.","journal-title":"Surgery."},{"key":"9199_CR49","unstructured":"National Center for Health Statistics. (2024) Infertility FastStats. Retrieved from https:\/\/www.cdc.gov\/nchs\/fastats\/infertility.htm. Accessed 1 May 2025"},{"key":"9199_CR50","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1093\/humrep\/der465.","volume":"27","author":"T Bushnik","year":"2012","unstructured":"Bushnik T, Cook JL, Yuzpe AA, Tough S, Collins J. Estimating the prevalence of infertility in Canada. Hum Reprod. 2012;27:738\u2013746. https:\/\/doi.org\/10.1093\/humrep\/der465.","journal-title":"Hum Reprod."},{"key":"9199_CR51","first-page":"308","volume":"91","author":"TJ Lindsay","year":"2015","unstructured":"Lindsay TJ, Vitrikas KR. Evaluation and treatment of infertility. Am Fam Physician. 2015;91:308\u2013314.","journal-title":"Am Fam Physician."},{"key":"9199_CR52","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1111\/apt.12478.","volume":"38","author":"N Tavernier","year":"2013","unstructured":"Tavernier N, Fumery M, Peyrin-Biroulet L, Colombel JF, Gower-Rousseau C. Systematic review: fertility in non-surgically treated inflammatory bowel disease. Aliment Pharmacol Ther. 2013;38:847\u2013853. https:\/\/doi.org\/10.1111\/apt.12478.","journal-title":"Aliment Pharmacol Ther."},{"key":"9199_CR53","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1093\/ecco-jcc\/jjaa191.","volume":"15","author":"E Druvefors","year":"2021","unstructured":"Druvefors E, Landerholm K, Hammar U, Myrelid P, Andersson RE. Impaired fertility in women with inflammatory bowel disease: a national cohort study from sweden. J Crohns Colitis. 2021;15:383\u2013390. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjaa191.","journal-title":"J Crohns Colitis."},{"key":"9199_CR54","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1016\/j.cgh.2019.08.031.","volume":"18","author":"S Friedman","year":"2020","unstructured":"Friedman S, Nielsen J, N\u00f8hr EA, J\u00f8lving LR, N\u00f8rg\u00e5rd BM. Comparison of time to pregnancy in women with and without inflammatory bowel diseases. Clin Gastroenterol Hepatol. 2020;18:1537-1544.e1. https:\/\/doi.org\/10.1016\/j.cgh.2019.08.031.","journal-title":"Clin Gastroenterol Hepatol."},{"key":"9199_CR55","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.14309\/ajg.0000000000001537.","volume":"116","author":"R Laube","year":"2021","unstructured":"Laube R, Tran Y, Paramsothy S, Leong RW. Assisted reproductive technology in crohn\u2019s disease and Ulcerative Colitis: a systematic review and meta-analysis. Am J Gastroenterol. 2021;116:2334\u20132344. https:\/\/doi.org\/10.14309\/ajg.0000000000001537.","journal-title":"Am J Gastroenterol."},{"key":"9199_CR56","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1053\/j.gastro.2018.12.022.","volume":"156","author":"U Mahadevan","year":"2019","unstructured":"Mahadevan U, Robinson C, Bernasko N et al. Inflammatory bowel disease in pregnancy clinical care pathway: a report from the American gastroenterological association IBD parenthood project working group. Gastroenterology. 2019;156:1508\u20131524. https:\/\/doi.org\/10.1053\/j.gastro.2018.12.022.","journal-title":"Gastroenterology."},{"key":"9199_CR57","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1007\/s11605-022-05317-w.","volume":"26","author":"KS Olortegui","year":"2022","unstructured":"Olortegui KS, Graham A, Hyman N. Staging Considerations for the Ileal Pouch-Anal Anastomosis. J Gastrointest Surg. 2022;26:1531\u20131536. https:\/\/doi.org\/10.1007\/s11605-022-05317-w.","journal-title":"J Gastrointest Surg."},{"key":"9199_CR58","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1136\/gutjnl-2015-311246.","volume":"65","author":"BM N\u00f8rg\u00e5rd","year":"2016","unstructured":"N\u00f8rg\u00e5rd BM, Larsen PV, Fedder J, de Silva PS, Larsen MD, Friedman S. Live birth and adverse birth outcomes in women with ulcerative colitis and Crohn\u2019s disease receiving assisted reproduction: a 20-year nationwide cohort study. Gut. 2016;65:767\u2013776. https:\/\/doi.org\/10.1136\/gutjnl-2015-311246.","journal-title":"Gut."},{"key":"9199_CR59","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1053\/j.gastro.2020.11.038.","volume":"160","author":"U Mahadevan","year":"2021","unstructured":"Mahadevan U, Long MD, Kane SV et al. Pregnancy and neonatal outcomes after fetal exposure to biologics and Thiopurines among women with inflammatory bowel disease. Gastroenterology. 2021;160:1131\u20131139. https:\/\/doi.org\/10.1053\/j.gastro.2020.11.038.","journal-title":"Gastroenterology."},{"key":"9199_CR60","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1097\/AOG.0000000000000978.","volume":"126","author":"U Mahadevan","year":"2015","unstructured":"Mahadevan U, Matro R. Care of the pregnant patient with inflammatory bowel disease. Obstet Gynecol. 2015;126:401\u2013412. https:\/\/doi.org\/10.1097\/AOG.0000000000000978.","journal-title":"Obstet Gynecol."},{"key":"9199_CR61","doi-asserted-by":"publisher","first-page":"6193275","DOI":"10.1155\/2016\/6193275.","volume":"2016","author":"VW Huang","year":"2016","unstructured":"Huang VW, Chang HJ, Kroeker KI et al. Management of inflammatory bowel disease during pregnancy and breastfeeding varies widely: a need for further education. Can J Gastroenterol Hepatol. 2016;2016:6193275. https:\/\/doi.org\/10.1155\/2016\/6193275.","journal-title":"Can J Gastroenterol Hepatol."},{"key":"9199_CR62","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1093\/fampra\/cms035.","volume":"30","author":"D Toomey","year":"2013","unstructured":"Toomey D, Waldron B. Family planning and inflammatory bowel disease: the patient and the practitioner. Fam Pract. 2013;30:64\u201368. https:\/\/doi.org\/10.1093\/fampra\/cms035.","journal-title":"Fam Pract."},{"key":"9199_CR63","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/1751-2980.12247.","volume":"16","author":"S Bharadwaj","year":"2015","unstructured":"Bharadwaj S, Kulkarni G, Shen B. Menstrual cycle, sex hormones in female inflammatory bowel disease patients with and without surgery. J Dig Dis. 2015;16:245\u2013255. https:\/\/doi.org\/10.1111\/1751-2980.12247.","journal-title":"J Dig Dis."},{"key":"9199_CR64","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1093\/ibd\/izx004.","volume":"24","author":"VS Rolston","year":"2018","unstructured":"Rolston VS, Boroujerdi L, Long MD et al. The influence of hormonal fluctuation on inflammatory bowel disease symptom severity-a cross-sectional cohort study. Inflamm Bowel Dis. 2018;24:387\u2013393. https:\/\/doi.org\/10.1093\/ibd\/izx004.","journal-title":"Inflamm Bowel Dis."},{"key":"9199_CR65","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1080\/13697137.2017.1360861.","volume":"20","author":"EK Donaldson","year":"2017","unstructured":"Donaldson EK, Huang V, Ross S, Sydora BC. Experience of menopause in women with inflammatory bowel disease: pilot study. Climacteric. 2017;20:545\u2013551. https:\/\/doi.org\/10.1080\/13697137.2017.1360861.","journal-title":"Climacteric."},{"key":"9199_CR66","first-page":"623","volume":"72","author":"A Lichtarowicz","year":"1989","unstructured":"Lichtarowicz A, Norman C, Calcraft B, Morris JS, Rhodes J, Mayberry J. A study of the menopause, smoking, and contraception in women with crohn\u2019s disease. Q J Med. 1989;72:623\u2013631.","journal-title":"Q J Med."},{"key":"9199_CR67","doi-asserted-by":"publisher","first-page":"027","DOI":"10.1093\/crocol\/otac027.","volume":"4","author":"VP Moktan","year":"2022","unstructured":"Moktan VP, Daoud ND, Tremaine WJ et al. A cohort study of the age at menopause in female patients with and without inflammatory bowel disease. Crohns & Colitis 360. 2022;4:027. https:\/\/doi.org\/10.1093\/crocol\/otac027.","journal-title":"Crohns & Colitis 360."},{"key":"9199_CR68","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1097\/GME.0000000000000775.","volume":"24","author":"SD Sullivan","year":"2017","unstructured":"Sullivan SD, Lehman A, Nathan NK, Thomson CA, Howard BV. Age of menopause and fracture risk in postmenopausal women randomized to calcium + Vitamin D, hormone therapy, or the combination: results from the Women\u2019s Health Initiative Clinical Trials. Menopause. 2017;24:371\u2013378. https:\/\/doi.org\/10.1097\/GME.0000000000000775.","journal-title":"Menopause."},{"key":"9199_CR69","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1097\/GME.0000000000000451.","volume":"22","author":"SD Sullivan","year":"2015","unstructured":"Sullivan SD, Lehman A, Thomas F et al. Effects of self-reported age at nonsurgical menopause on time to first fracture and bone mineral density in the Women\u2019s Health Initiative observational study. Menopause. 2015;22:1035\u20131044. https:\/\/doi.org\/10.1097\/GME.0000000000000451.","journal-title":"Menopause."},{"key":"9199_CR70","doi-asserted-by":"publisher","first-page":"e003769","DOI":"10.1161\/JAHA.116.003769.","volume":"5","author":"D Appiah","year":"2016","unstructured":"Appiah D, Schreiner PJ, Demerath EW, Loehr LR, Chang PP, Folsom AR. Association of age at menopause with incident heart failure: a prospective cohort study and meta-analysis. J Am Heart Assoc. 2016;5:e003769. https:\/\/doi.org\/10.1161\/JAHA.116.003769.","journal-title":"J Am Heart Assoc."},{"key":"9199_CR71","doi-asserted-by":"publisher","first-page":"e553","DOI":"10.1016\/S2468-2667(19)30155-0.","volume":"4","author":"D Zhu","year":"2019","unstructured":"Zhu D, Chung HF, Dobson AJ et al. Age at natural menopause and risk of incident cardiovascular disease: a pooled analysis of individual patient data. Lancet Public Health. 2019;4:e553\u2013e564. https:\/\/doi.org\/10.1016\/S2468-2667(19)30155-0.","journal-title":"Lancet Public Health."},{"key":"9199_CR72","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.mcna.2015.01.006.","volume":"99","author":"TA Takahashi","year":"2015","unstructured":"Takahashi TA, Johnson KM. Menopause. Med Clin North Am. 2015;99:521\u2013534. https:\/\/doi.org\/10.1016\/j.mcna.2015.01.006.","journal-title":"Med Clin North Am."},{"key":"9199_CR73","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1111\/j.1572-0241.2007.01700.x.","volume":"103","author":"SV Kane","year":"2008","unstructured":"Kane SV, Reddy D. Hormonal replacement therapy after menopause is protective of disease activity in women with inflammatory bowel disease. Am J Gastroenterol. 2008;103:1193\u20131196. https:\/\/doi.org\/10.1111\/j.1572-0241.2007.01700.x.","journal-title":"Am J Gastroenterol."},{"key":"9199_CR74","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1001\/jama.288.3.321.","volume":"288","author":"JE Rossouw","year":"2002","unstructured":"Rossouw JE, Anderson GL, Prentice RL et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women\u2019s Health Initiative randomized controlled trial. JAMA. 2002;288:321\u2013333. https:\/\/doi.org\/10.1001\/jama.288.3.321.","journal-title":"JAMA."},{"key":"9199_CR75","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.1111\/j.1572-0241.2008.02064.x.","volume":"103","author":"JA Cornish","year":"2008","unstructured":"Cornish JA, Tan E, Simillis C, Clark SK, Teare J, Tekkis PP. The risk of oral contraceptives in the etiology of inflammatory bowel disease: a meta-analysis. Am J Gastroenterol. 2008;103:2394\u20132400. https:\/\/doi.org\/10.1111\/j.1572-0241.2008.02064.x.","journal-title":"Am J Gastroenterol."},{"key":"9199_CR76","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1053\/j.gastro.2012.07.096.","volume":"143","author":"H Khalili","year":"2012","unstructured":"Khalili H, Higuchi LM, Ananthakrishnan AN et al. Hormone therapy increases risk of ulcerative colitis but not Crohn\u2019s disease. Gastroenterology. 2012;143:1199\u20131206. https:\/\/doi.org\/10.1053\/j.gastro.2012.07.096.","journal-title":"Gastroenterology."},{"key":"9199_CR77","unstructured":"World Health Organization. (2024) Cervical Cancer. Retrieved from https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/cervical-cancer. Accessed 1 May 2025"},{"key":"9199_CR78","unstructured":"National Cancer Institute. (2022) Cancer Stat Facts: Cervical Cancer. Retrieved from https:\/\/seer.cancer.gov\/statfacts\/html\/cervix.html. Accessed 1 May 2025"},{"key":"9199_CR79","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1016\/S0140-6736(11)60551-5.","volume":"377","author":"JML Brotherton","year":"2011","unstructured":"Brotherton JML, Fridman M, May CL, Chappell G, Saville AM, Gertig DM. Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study. Lancet. 2011;377:2085\u20132092. https:\/\/doi.org\/10.1016\/S0140-6736(11)60551-5.","journal-title":"Lancet."},{"key":"9199_CR80","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/S0140-6736(20)30068-4.","volume":"395","author":"M Brisson","year":"2020","unstructured":"Brisson M, Kim JJ, Canfell K et al. Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries. Lancet. 2020;395:575\u2013590. https:\/\/doi.org\/10.1016\/S0140-6736(20)30068-4.","journal-title":"Lancet."},{"key":"9199_CR81","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1097\/aog.0b013e318277c92a.","volume":"120","author":"Committee on Practice Bulletins-Gynecology","year":"2012","unstructured":"Committee on Practice Bulletins-Gynecology. ACOG practice bulletin number 131: screening for cervical cancer. Obstet Gynecol. 2012;120:1222\u20131238. https:\/\/doi.org\/10.1097\/aog.0b013e318277c92a.","journal-title":"Obstet Gynecol."},{"key":"9199_CR82","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.crohns.2013.04.006.","volume":"8","author":"F Magro","year":"2014","unstructured":"Magro F, Peyrin-Biroulet L, Sokol H et al. Extra-intestinal malignancies in inflammatory bowel disease: results of the 3rd ECCO Pathogenesis Scientific Workshop (III). J Crohns Colitis. 2014;8:31\u201344. https:\/\/doi.org\/10.1016\/j.crohns.2013.04.006.","journal-title":"J Crohns Colitis."},{"key":"9199_CR83","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1093\/ecco-jcc\/jjac187.","volume":"17","author":"H Gordon","year":"2023","unstructured":"Gordon H, Biancone L, Fiorino G et al. ECCO guidelines on inflammatory bowel disease and malignancies. J Crohns Colitis. 2023;17:827\u2013854. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjac187.","journal-title":"J Crohns Colitis."},{"key":"9199_CR84","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1097\/MIB.0b013e318281341b.","volume":"19","author":"DL Jacobson","year":"2013","unstructured":"Jacobson DL, Bousvaros A, Ashworth L et al. Immunogenicity and tolerability to human papillomavirus-like particle vaccine in girls and young women with inflammatory bowel disease. Inflamm Bowel Dis. 2013;19:1441\u20131449. https:\/\/doi.org\/10.1097\/MIB.0b013e318281341b.","journal-title":"Inflamm Bowel Dis."},{"key":"9199_CR85","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1093\/ecco-jcc\/jjx035.","volume":"11","author":"A Wisniewski","year":"2017","unstructured":"Wisniewski A, Fl\u00e9jou JF, Siproudhis L, Abramowitz L, Svrcek M, Beaugerie L. Anal Neoplasia in inflammatory bowel disease: classification proposal, epidemiology, carcinogenesis, and risk management perspectives. J Crohns Colitis. 2017;11:1011\u20131018. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjx035.","journal-title":"J Crohns Colitis."},{"key":"9199_CR86","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1093\/ibd\/izaa035.","volume":"27","author":"JP Segal","year":"2021","unstructured":"Segal JP, Askari A, Clark SK, Hart AL, Faiz OD. The incidence and prevalence of human papilloma virus-associated cancers in IBD. Inflamm Bowel Dis. 2021;27:34\u201339. https:\/\/doi.org\/10.1093\/ibd\/izaa035.","journal-title":"Inflamm Bowel Dis."},{"key":"9199_CR87","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1016\/j.cgh.2015.05.031.","volume":"13","author":"SB Shah","year":"2015","unstructured":"Shah SB, Pickham D, Araya H et al. Prevalence of anal dysplasia in patients with inflammatory bowel disease. Clin Gastroenterol Hepatol. 2015;13:1955-1961.e1. https:\/\/doi.org\/10.1016\/j.cgh.2015.05.031.","journal-title":"Clin Gastroenterol Hepatol."},{"key":"9199_CR88","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.cgh.2015.09.041.","volume":"14","author":"KH Katsanos","year":"2016","unstructured":"Katsanos KH, Roda G, McBride RB, Cohen B, Colombel JF. Increased risk of oral cancer in patients with inflammatory bowel diseases. Clin Gastroenterol Hepatol. 2016;14:413\u2013420. https:\/\/doi.org\/10.1016\/j.cgh.2015.09.041.","journal-title":"Clin Gastroenterol Hepatol."},{"key":"9199_CR89","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1080\/00365521.2023.2238101.","volume":"58","author":"J Kim","year":"2023","unstructured":"Kim J, Jung JH, Jo H, Kim MH, Kang DR, Kim HM. Risk of uterine cervical cancer in inflammatory bowel disease: a systematic review and meta-analysis. Scand J Gastroenterol. 2023;58:1412\u20131421. https:\/\/doi.org\/10.1080\/00365521.2023.2238101.","journal-title":"Scand J Gastroenterol."},{"key":"9199_CR90","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1097\/MIB.0000000000000338.","volume":"21","author":"JR Allegretti","year":"2015","unstructured":"Allegretti JR, Barnes EL, Cameron A. Are patients with inflammatory bowel disease on chronic immunosuppressive therapy at increased risk of cervical high-grade dysplasia\/cancer? a meta-analysis. Inflamm Bowel Dis. 2015;21:1089\u20131097. https:\/\/doi.org\/10.1097\/MIB.0000000000000338.","journal-title":"Inflamm Bowel Dis."},{"key":"9199_CR91","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1080\/09513590.2017.1416466.","volume":"34","author":"E Waszczuk","year":"2018","unstructured":"Waszczuk E, Waszczuk K, Bohdanowicz-Pawlak A, Florja\u0144ski J. Women with inflammatory bowel diseases have a suboptimal cervical cancer screening rate and are not aware of the recommended human papilloma virus vaccine. Gynecol Endocrinol. 2018;34:656\u2013658. https:\/\/doi.org\/10.1080\/09513590.2017.1416466.","journal-title":"Gynecol Endocrinol."},{"key":"9199_CR92","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s40615-015-0112-0.","volume":"3","author":"JE Rivera-Acosta","year":"2016","unstructured":"Rivera-Acosta JE, Aponte M, Villamil I, Romaguera J, Ortiz AP, Torres EA. Human Papilloma virus awareness among hispanic females with inflammatory bowel disease. J Racial Ethn Health Disparities. 2016;3:55\u201362. https:\/\/doi.org\/10.1007\/s40615-015-0112-0.","journal-title":"J Racial Ethn Health Disparities."},{"key":"9199_CR93","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1002\/ibd.21567.","volume":"17","author":"H Singh","year":"2011","unstructured":"Singh H, Nugent Z, Demers AA, Bernstein CN. Screening for cervical and breast cancer among women with inflammatory bowel disease: a population-based study. Inflamm Bowel Dis. 2011;17:1741\u20131750. https:\/\/doi.org\/10.1002\/ibd.21567.","journal-title":"Inflamm Bowel Dis."},{"key":"9199_CR94","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1007\/s10620-019-05494-w.","volume":"64","author":"F Xu","year":"2019","unstructured":"Xu F, Dahlhamer JM, Terlizzi EP, Wheaton AG, Croft JB. Receipt of preventive care services among US adults with inflammatory bowel disease, 2015\u20132016. Dig Dis Sci. 2019;64:1798\u20131808. https:\/\/doi.org\/10.1007\/s10620-019-05494-w.","journal-title":"Dig Dis Sci."},{"key":"9199_CR95","doi-asserted-by":"publisher","first-page":"e111","DOI":"10.1097\/AOG.0000000000001708.","volume":"128","author":"Committee on Practice Bulletins\u2014Gynecology","year":"2016","unstructured":"Committee on Practice Bulletins\u2014Gynecology. ACOG practice bulletin no. 168: cervical cancer screening and prevention. Obstet Gynecol. 2016;128:e111\u2013e130. https:\/\/doi.org\/10.1097\/AOG.0000000000001708.","journal-title":"Obstet Gynecol."},{"key":"9199_CR96","doi-asserted-by":"publisher","first-page":"208","DOI":"10.14740\/gr1287.","volume":"13","author":"A Chhaparia","year":"2020","unstructured":"Chhaparia A, Odufalu F, Edwards M et al. Cervical cancer screening in inflammatory bowel disease: who should be screening? Gastroenterol Res. 2020;13:208\u2013216. https:\/\/doi.org\/10.14740\/gr1287.","journal-title":"Gastroenterol Res."},{"key":"9199_CR97","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1093\/ibd\/izab247.","volume":"28","author":"N Yu","year":"2022","unstructured":"Yu N, Basnayake C, Connell W et al. Interventions to improve adherence to preventive care in inflammatory bowel disease: a systematic review. Inflamm Bowel Dis. 2022;28:1177\u20131188. https:\/\/doi.org\/10.1093\/ibd\/izab247.","journal-title":"Inflamm Bowel Dis."},{"key":"9199_CR98","unstructured":"U.S. Department of Health and Human Services. (2024) U. S. Cancer Statistics Data Visualizations Tool. Retrieved from https:\/\/www.cdc.gov\/cancer\/dataviz. Accessed 1 May 2025"},{"key":"9199_CR99","doi-asserted-by":"publisher","first-page":"279","DOI":"10.7326\/M15-2886.","volume":"164","author":"AL Siu","year":"2016","unstructured":"Siu AL, U.S. Preventive Services Task Force. Screening for breast cancer: U.S. preventive services task force recommendation statement. Ann Intern Med. 2016;164:279\u2013296. https:\/\/doi.org\/10.7326\/M15-2886.","journal-title":"Ann Intern Med."},{"key":"9199_CR100","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1038\/ajg.2009.760.","volume":"105","author":"N Pedersen","year":"2010","unstructured":"Pedersen N, Duricova D, Elkjaer M, Gamborg M, Munkholm P, Jess T. Risk of extra-intestinal cancer in inflammatory bowel disease: meta-analysis of population-based cohort studies. Am J Gastroenterol. 2010;105:1480\u20131487. https:\/\/doi.org\/10.1038\/ajg.2009.760.","journal-title":"Am J Gastroenterol."},{"key":"9199_CR101","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1097\/CEJ.0000000000000667.","volume":"31","author":"C Gong","year":"2022","unstructured":"Gong C, Xu R, Zou P, Zhang Y, Wang X. Inflammatory bowel disease and risk of breast cancer: a meta-analysis of cohort studies. Eur J Cancer Prev. 2022;31:54\u201363. https:\/\/doi.org\/10.1097\/CEJ.0000000000000667.","journal-title":"Eur J Cancer Prev."},{"key":"9199_CR102","doi-asserted-by":"publisher","first-page":"S83","DOI":"10.1093\/jcag\/gwad006.","volume":"6","author":"SK Murthy","year":"2023","unstructured":"Murthy SK, Kuenzig ME, Windsor JW et al. The 2023 impact of inflammatory bowel disease in Canada: cancer and IBD. J Can Assoc Gastroenterol. 2023;6:S83\u2013S96. https:\/\/doi.org\/10.1093\/jcag\/gwad006.","journal-title":"J Can Assoc Gastroenterol."},{"key":"9199_CR103","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/ajg.2013.441.","volume":"109","author":"GR Lichtenstein","year":"2014","unstructured":"Lichtenstein GR, Feagan BG, Cohen RD et al. Drug therapies and the risk of malignancy in Crohn\u2019s disease: results from the TREAT\u2122 registry. Am J Gastroenterol. 2014;109:212\u2013223. https:\/\/doi.org\/10.1038\/ajg.2013.441.","journal-title":"Am J Gastroenterol."},{"key":"9199_CR104","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1002\/ijc.30183.","volume":"139","author":"TRA van den Heuvel","year":"2016","unstructured":"van den Heuvel TRA, Wintjens DSJ, Jeuring SFG et al. Inflammatory bowel disease, cancer and medication: cancer risk in the Dutch population-based IBDSL cohort. Int J Cancer. 2016;139:1270\u20131280. https:\/\/doi.org\/10.1002\/ijc.30183.","journal-title":"Int J Cancer."},{"key":"9199_CR105","doi-asserted-by":"publisher","first-page":"457","DOI":"10.14740\/wjon1644.","volume":"14","author":"RK Patel","year":"2023","unstructured":"Patel RK, Frankel L, Cardeiro M, Hansen W, Takabe K, Rashid OM. The role of crohn disease on breast cancer incidence: a clinical analysis. World J Oncol. 2023;14:457\u2013463. https:\/\/doi.org\/10.14740\/wjon1644.","journal-title":"World J Oncol."},{"key":"9199_CR106","doi-asserted-by":"publisher","first-page":"2406","DOI":"10.1001\/jama.2014.5613.","volume":"311","author":"NN Andersen","year":"2014","unstructured":"Andersen NN, Pasternak B, Basit S et al. Association between tumor necrosis factor-\u03b1 antagonists and risk of cancer in patients with inflammatory bowel disease. JAMA. 2014;311:2406\u20132413. https:\/\/doi.org\/10.1001\/jama.2014.5613.","journal-title":"JAMA."},{"key":"9199_CR107","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1038\/ajg.2009.745.","volume":"105","author":"RG Armstrong","year":"2010","unstructured":"Armstrong RG, West J, Card TR. Risk of cancer in inflammatory bowel disease treated with Azathioprine: a UK population-based case-control study. Am J Gastroenterol. 2010;105:1604\u20131609. https:\/\/doi.org\/10.1038\/ajg.2009.745.","journal-title":"Am J Gastroenterol."},{"key":"9199_CR108","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1093\/aje\/kws375.","volume":"177","author":"B Pasternak","year":"2013","unstructured":"Pasternak B, Svanstr\u00f6m H, Schmiegelow K, Jess T, Hviid A. Use of azathioprine and the risk of cancer in inflammatory bowel disease. Am J Epidemiol. 2013;177:1296\u20131305. https:\/\/doi.org\/10.1093\/aje\/kws375.","journal-title":"Am J Epidemiol."},{"key":"9199_CR109","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1056\/NEJMc1602599.","volume":"374","author":"DM Black","year":"2016","unstructured":"Black DM, Rosen CJ. Postmenopausal osteoporosis. N Engl J Med. 2016;374:254\u2013262. https:\/\/doi.org\/10.1056\/NEJMc1602599.","journal-title":"N Engl J Med."},{"key":"9199_CR110","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1001\/jama.2018.7498.","volume":"319","author":"SJ Curry","year":"2018","unstructured":"Curry SJ, Krist AH, Owens DK et al. Screening for osteoporosis to prevent fractures: US preventive services task force recommendation statement. JAMA. 2018;319:2521\u20132531. https:\/\/doi.org\/10.1001\/jama.2018.7498.","journal-title":"JAMA."},{"key":"9199_CR111","doi-asserted-by":"publisher","first-page":"5362","DOI":"10.3748\/wjg.v26.i35.5362.","volume":"26","author":"S K\u00e4rnsund","year":"2020","unstructured":"K\u00e4rnsund S, Lo B, Bendtsen F, Holm J, Burisch J. Systematic review of the prevalence and development of osteoporosis or low bone mineral density and its risk factors in patients with inflammatory bowel disease. World J Gastroenterol. 2020;26:5362\u20135374. https:\/\/doi.org\/10.3748\/wjg.v26.i35.5362.","journal-title":"World J Gastroenterol."},{"key":"9199_CR112","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1053\/gast.2003.50106.","volume":"124","author":"CN Bernstein","year":"2003","unstructured":"Bernstein CN, Leslie WD, Leboff MS. AGA technical review on osteoporosis in gastrointestinal diseases. Gastroenterology. 2003;124:795\u2013841. https:\/\/doi.org\/10.1053\/gast.2003.50106.","journal-title":"Gastroenterology."},{"key":"9199_CR113","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1093\/ecco-jcc\/jjaa052.","volume":"14","author":"J Bartko","year":"2020","unstructured":"Bartko J, Reichardt B, Kocijan R, Klaushofer K, Zwerina J, Behanova M. Inflammatory bowel disease: a Nationwide study of hip fracture and mortality risk after hip fracture. J Crohns Colitis. 2020;14:1684\u20131691. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjaa052.","journal-title":"J Crohns Colitis."},{"key":"9199_CR114","doi-asserted-by":"publisher","first-page":"291","DOI":"10.14309\/ajg.0000000000000062.","volume":"114","author":"JF Ludvigsson","year":"2019","unstructured":"Ludvigsson JF, Mahl M, Sachs MC et al. Fracture risk in patients with inflammatory bowel disease: a nationwide population-based cohort study from 1964 to 2014. Am J Gastroenterol. 2019;114:291\u2013304. https:\/\/doi.org\/10.14309\/ajg.0000000000000062.","journal-title":"Am J Gastroenterol."},{"key":"9199_CR115","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1359\/jbmr.2000.15.6.993.","volume":"15","author":"TP Van Staa","year":"2000","unstructured":"Van Staa TP, Leufkens HGM, Abenhaim L, Zhang B, Cooper C. Use of oral corticosteroids and risk of fractures. J Bone Miner Res. 2000;15:993\u20131000. https:\/\/doi.org\/10.1359\/jbmr.2000.15.6.993.","journal-title":"J Bone Miner Res."},{"key":"9199_CR116","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1002\/acr.20295.","volume":"62","author":"JM Grossman","year":"2010","unstructured":"Grossman JM, Gordon R, Ranganath VK et al. American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Care Res. 2010;62:1515\u20131526. https:\/\/doi.org\/10.1002\/acr.20295.","journal-title":"Arthritis Care Res."},{"key":"9199_CR117","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s00198-012-2224-2.","volume":"24","author":"RL Prentice","year":"2013","unstructured":"Prentice RL, Pettinger MB, Jackson RD et al. Health risks and benefits from calcium and vitamin D supplementation: Women\u2019s Health Initiative clinical trial and cohort study. Osteoporos Int. 2013;24:567\u2013580. https:\/\/doi.org\/10.1007\/s00198-012-2224-2.","journal-title":"Osteoporos Int."},{"key":"9199_CR118","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1056\/NEJMoa055218.","volume":"354","author":"RD Jackson","year":"2006","unstructured":"Jackson RD, LaCroix AZ, Gass M et al. Calcium plus Vitamin D supplementation and the risk of fractures. N Engl J Med. 2006;354:669\u2013683. https:\/\/doi.org\/10.1056\/NEJMoa055218.","journal-title":"N Engl J Med."},{"key":"9199_CR119","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1046\/j.1365-2036.2002.01247.x.","volume":"16","author":"V Abitbol","year":"2002","unstructured":"Abitbol V, Mary JY, Roux C et al. Osteoporosis in inflammatory bowel disease: effect of calcium and vitamin D with or without fluoride. Alimentary Pharmacol Ther. 2002;16:919\u2013927. https:\/\/doi.org\/10.1046\/j.1365-2036.2002.01247.x.","journal-title":"Alimentary Pharmacol Ther."},{"key":"9199_CR120","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.crohns.2012.06.003.","volume":"7","author":"SF Bakker","year":"2013","unstructured":"Bakker SF, Dik VK, Witte BI, Lips P, Roos JC, Van Bodegraven AA. Increase in bone mineral density in strictly treated Crohn\u2019s disease patients with concomitant calcium and vitamin D supplementation. J Crohns Colitis. 2013;7:377\u2013384. https:\/\/doi.org\/10.1016\/j.crohns.2012.06.003.","journal-title":"J Crohns Colitis."},{"key":"9199_CR121","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.cgh.2013.08.024.","volume":"12","author":"J Melek","year":"2014","unstructured":"Melek J, Sakuraba A. Efficacy and safety of medical therapy for low bone mineral density in patients with inflammatory bowel disease: a meta-analysis and systematic review. Clin Gastroenterol Hepatol. 2014;12:32-44.e5. https:\/\/doi.org\/10.1016\/j.cgh.2013.08.024.","journal-title":"Clin Gastroenterol Hepatol."},{"key":"9199_CR122","doi-asserted-by":"publisher","first-page":"e5861","DOI":"10.1097\/MD.0000000000005861.","volume":"96","author":"L Yao","year":"2017","unstructured":"Yao L, Wang H, Dong W, Liu Z, Mao H. Efficacy and safety of bisphosphonates in management of low bone density in inflammatory bowel disease: a meta-analysis. Medicine (Baltimore). 2017;96:e5861. https:\/\/doi.org\/10.1097\/MD.0000000000005861.","journal-title":"Medicine (Baltimore)."},{"key":"9199_CR123","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1136\/gutjnl-2013-306141.","volume":"63","author":"CN Bernstein","year":"2014","unstructured":"Bernstein CN, Targownik LE, Leslie WD. What is the role for bisphosphonates in IBD? Gut. 2014;63:1369\u20131370. https:\/\/doi.org\/10.1136\/gutjnl-2013-306141.","journal-title":"Gut."},{"key":"9199_CR124","first-page":"1","volume":"68","author":"M Heron","year":"2019","unstructured":"Heron M. Deaths: leading causes for 2017. Natl Vital Stat Rep. 2019;68:1\u201377.","journal-title":"Natl Vital Stat Rep."},{"key":"9199_CR125","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1136\/heartjnl-2015-308769.","volume":"102","author":"AA Merz","year":"2016","unstructured":"Merz AA, Cheng S. Sex differences in cardiovascular ageing. Heart. 2016;102:825\u2013831. https:\/\/doi.org\/10.1136\/heartjnl-2015-308769.","journal-title":"Heart."},{"key":"9199_CR126","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1002\/clc.4960280809.","volume":"28","author":"A Abuful","year":"2005","unstructured":"Abuful A, Gidron Y, Henkin Y. Physicians\u2019 attitudes toward preventive therapy for coronary artery disease: is there a gender bias? Clin Cardiol. 2005;28:389\u2013393. https:\/\/doi.org\/10.1002\/clc.4960280809.","journal-title":"Clin Cardiol."},{"key":"9199_CR127","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1161\/01.CIR.0000154568.43333.82.","volume":"111","author":"L Mosca","year":"2005","unstructured":"Mosca L, Linfante AH, Benjamin EJ et al. National study of physician awareness and adherence to cardiovascular disease prevention guidelines. Circulation. 2005;111:499\u2013510. https:\/\/doi.org\/10.1161\/01.CIR.0000154568.43333.82.","journal-title":"Circulation."},{"key":"9199_CR128","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.1161\/CIRCULATIONAHA.108.789800.","volume":"118","author":"H Jneid","year":"2008","unstructured":"Jneid H, Fonarow GC, Cannon CP et al. Sex differences in medical care and early death after acute myocardial infarction. Circulation. 2008;118:2803\u20132810. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.108.789800.","journal-title":"Circulation."},{"key":"9199_CR129","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1161\/CIRCULATIONAHA.105.561647.","volume":"113","author":"C Daly","year":"2006","unstructured":"Daly C, Clemens F, Lopez Sendon JL et al. Gender differences in the management and clinical outcome of stable angina. Circulation. 2006;113:490\u2013498. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.105.561647.","journal-title":"Circulation."},{"key":"9199_CR130","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.jacc.2004.11.055.","volume":"45","author":"AL Blomkalns","year":"2005","unstructured":"Blomkalns AL, Chen AY, Hochman JS et al. Gender disparities in the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: large-scale observations from the CRUSADE National Quality Improvement Initiative. J Am Coll Cardiol. 2005;45:832\u2013837. https:\/\/doi.org\/10.1016\/j.jacc.2004.11.055.","journal-title":"J Am Coll Cardiol."},{"key":"9199_CR131","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1136\/annrheumdis-2013-205058.","volume":"74","author":"I Del Rinc\u00f3n","year":"2015","unstructured":"Del Rinc\u00f3n I, Polak JF, O\u2019Leary DH et al. Systemic inflammation and cardiovascular risk factors predict rapid progression of atherosclerosis in rheumatoid arthritis. Ann Rheum Dis. 2015;74:1118\u20131123. https:\/\/doi.org\/10.1136\/annrheumdis-2013-205058.","journal-title":"Ann Rheum Dis."},{"key":"9199_CR132","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1136\/ard.2009.113696.","volume":"69","author":"MJL Peters","year":"2010","unstructured":"Peters MJL, Symmons DPM, McCarey D et al. EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis. 2010;69:325\u2013331. https:\/\/doi.org\/10.1136\/ard.2009.113696.","journal-title":"Ann Rheum Dis."},{"key":"9199_CR133","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.cgh.2013.08.023.","volume":"12","author":"S Singh","year":"2014","unstructured":"Singh S, Singh H, Loftus EV, Pardi DS. Risk of cerebrovascular accidents and ischemic heart disease in patients with inflammatory bowel disease: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2014;12:382-393.e1. https:\/\/doi.org\/10.1016\/j.cgh.2013.08.023.","journal-title":"Clin Gastroenterol Hepatol."},{"key":"9199_CR134","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1136\/gutjnl-2017-314015.","volume":"67","author":"J Kirchgesner","year":"2018","unstructured":"Kirchgesner J, Beaugerie L, Carrat F et al. Increased risk of acute arterial events in young patients and severely active IBD: a nationwide French cohort study. Gut. 2018;67:1261\u20131268. https:\/\/doi.org\/10.1136\/gutjnl-2017-314015.","journal-title":"Gut."},{"key":"9199_CR135","doi-asserted-by":"publisher","first-page":"181","DOI":"10.2174\/1389450116666150202161500.","volume":"16","author":"R Schicho","year":"2015","unstructured":"Schicho R, Marsche G, Storr M. Cardiovascular complications in inflammatory bowel disease. Curr Drug Targets. 2015;16:181\u2013188. https:\/\/doi.org\/10.2174\/1389450116666150202161500.","journal-title":"Curr Drug Targets."},{"key":"9199_CR136","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1016\/j.metabol.2006.03.006.","volume":"55","author":"B Ripoll\u00e9s Piquer","year":"2006","unstructured":"Ripoll\u00e9s Piquer B, Nazih H, Bourreille A et al. Altered lipid, apolipoprotein, and lipoprotein profiles in inflammatory bowel disease: consequences on the cholesterol efflux capacity of serum using Fu5AH cell system. Metabolism. 2006;55:980\u2013988. https:\/\/doi.org\/10.1016\/j.metabol.2006.03.006.","journal-title":"Metabolism."},{"key":"9199_CR137","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.jacl.2010.08.021.","volume":"4","author":"RSR Sappati Biyyani","year":"2010","unstructured":"Sappati Biyyani RSR, Putka BS, Mullen KD. Dyslipidemia and lipoprotein profiles in patients with inflammatory bowel disease. J Clin Lipidol. 2010;4:478\u2013482. https:\/\/doi.org\/10.1016\/j.jacl.2010.08.021.","journal-title":"J Clin Lipidol."},{"key":"9199_CR138","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.pharmthera.2012.12.001.","volume":"137","author":"G Marsche","year":"2013","unstructured":"Marsche G, Saemann MD, Heinemann A, Holzer M. Inflammation alters HDL composition and function: implications for HDL-raising therapies. Pharmacol Ther. 2013;137:341\u2013351. https:\/\/doi.org\/10.1016\/j.pharmthera.2012.12.001.","journal-title":"Pharmacol Ther."},{"key":"9199_CR139","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1038\/ajg.2009.81.","volume":"104","author":"C Ha","year":"2009","unstructured":"Ha C, Magowan S, Accortt NA, Chen J, Stone CD. Risk of arterial thrombotic events in inflammatory bowel disease. Am J Gastroenterol. 2009;104:1445\u20131451. https:\/\/doi.org\/10.1038\/ajg.2009.81.","journal-title":"Am J Gastroenterol."},{"key":"9199_CR140","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.atherosclerosis.2015.03.044.","volume":"241","author":"L Gianturco","year":"2014","unstructured":"Gianturco L, Bodini BD, Atzeni F et al. Cardiovascular and autoimmune diseases in females: the role of microvasculature and dysfunctional endothelium. Atherosclerosis. 2014;241:259\u2013263. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2015.03.044.","journal-title":"Atherosclerosis."},{"key":"9199_CR141","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1136\/gutjnl-2019-318932.","volume":"69","author":"J Kirchgesner","year":"2020","unstructured":"Kirchgesner J, Nyboe Andersen N, Carrat F et al. Risk of acute arterial events associated with treatment of inflammatory bowel diseases: Nationwide French cohort study. Gut. 2020;69:852\u2013858. https:\/\/doi.org\/10.1136\/gutjnl-2019-318932.","journal-title":"Gut."},{"key":"9199_CR142","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1006\/phrs.1998.0463.","volume":"40","author":"R Ferrari","year":"1999","unstructured":"Ferrari R. The role of TNF in cardiovascular disease. Pharmacol Res. 1999;40:97\u2013105. https:\/\/doi.org\/10.1006\/phrs.1998.0463.","journal-title":"Pharmacol Res."},{"key":"9199_CR143","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s00296-009-0935-2.","volume":"30","author":"A Ferrante","year":"2009","unstructured":"Ferrante A, Giardina AR, Ciccia F et al. Long-term anti-tumour necrosis factor therapy reverses the progression of carotid intima-media thickness in female patients with active rheumatoid arthritis. Rheumatol Int. 2009;30:193\u2013198. https:\/\/doi.org\/10.1007\/s00296-009-0935-2.","journal-title":"Rheumatol Int."},{"key":"9199_CR144","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1002\/art.21707.","volume":"55","author":"C Gonzalez-Juanatey","year":"2006","unstructured":"Gonzalez-Juanatey C, Llorca J, Garcia-Porrua C, Martin J, Gonzalez-Gay MA. Effect of anti-tumor necrosis factor \u03b1 therapy on the progression of subclinical atherosclerosis in severe rheumatoid arthritis. Arthritis Care Res. 2006;55:150\u2013153. https:\/\/doi.org\/10.1002\/art.21707.","journal-title":"Arthritis Care Res."},{"key":"9199_CR145","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1016\/j.cgh.2020.02.047.","volume":"18","author":"CH Lo","year":"2020","unstructured":"Lo CH, Khalili H, Song M et al. Healthy lifestyle is associated with reduced mortality in patients with inflammatory bowel diseases. Clin Gastroenterol Hepatol. 2020;18:1525\u20131532. https:\/\/doi.org\/10.1016\/j.cgh.2020.02.047.","journal-title":"Clin Gastroenterol Hepatol."}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-025-09199-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-025-09199-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-025-09199-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T04:53:42Z","timestamp":1763441622000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-025-09199-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,8]]},"references-count":145,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["9199"],"URL":"https:\/\/doi.org\/10.1007\/s10620-025-09199-1","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"type":"print","value":"0163-2116"},{"type":"electronic","value":"1573-2568"}],"subject":[],"published":{"date-parts":[[2025,7,8]]},"assertion":[{"value":"8 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Vivian Huang has the following conflicts of interest to report: Abbvie: Advisor committees or Review Panels\u2014same for Janssen, Pfizer, Merck, Takeda, Ferring, Roche; Abbvie, Janssen, Ferring, Takeda\u2014speaking and teaching. Parul Tandon has the following conflicts of interest to report\u2014Abbvie, Janssen, Takeda: Speaker; Janssen, Takeda: Advisory board","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}